Brief: Medincell Launches A Private Placement For International Institutional Investors
March 5 (Reuters) - Medincell SA MEDCL.PA: MEDINCELL LAUNCHES A PRIVATE PLACEMENT FOR INTERNATIONAL INSTITUTIONAL INVESTORS LAUNCHES PRIVATE PLACEMENT OF ABOUT 6% OF SHARE CAPITAL BOOK-BUILDING FOR PRIVATE PLACEMENT EXPECTED TO CLOSE BEFORE MARCH 6, 2026 MARKET OPEN SETTLEMENT AND ADMISSION OF NEW SHARES EXPECTED ON MARCH 10, 2026 PRIVATE PLACEMENT MAY ISSUE UP TO 5,749,064 SHARES, MAXIMUM 17% OF CAPITAL Source text: nBw58s10pa Further company coverage: MEDCL.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris